Early Bird registration opens today for the October 12-16, 2015 Emerson Exchange conference in Denver, Colorado. You’ll save $200 USD by registering by August 15. You can see the full list of accepted presentation abstracts here.
I’ll highlight several more of the Emerson subject matter experts presenting at the conference to help give you a flavor of some of the knowledge sharing that will occur.
Justifying automation projects is critical for approval. Benefits need to be identified and financial gains determined. Obsolescence may be a reality, but just trying to replace the equipment will not guarantee a ‘green light’ to move your project forward. This short course will focus on the early justification/planning process, where to look for the benefits/opportunities, estimating the financial value as well as the cost, and how to perform the return calculations. We will cover some real world examples from several industries, such as Chemicals, Pulp & Paper, Metals & Mining, and Refining.
Emerson’s Barbara Hamilton will present, Leading with Influence – The art and science of getting things done. Her abstract:
Few organizations operate in a purely hierarchical structure and the economic pressure to reduce management layers relentlessly continues. But organizations are simultaneously faced with a complex landscape that demands agility, innovation, and collaboration. So how can one leverage his/her network to accomplish these goals? The ability to lead by influencing others is crucial. This workshop examines how to develop that skill up, down and sideways, and how businesses can create an environment where leading by influence is recognized and valued.
And, Emerson’s Jonathan Lustri will present, SmartMES – Developing an OEM EBR [electronic batch record] solution for Single Use Biotech. His abstract:
Finesse introduces SmartMES, a pre-built and configurable electronic batch records solution for single use biotech processes.
Finesse’s SmartMES is an OEM delivered Syncade application designed for single use biotech processes and is generic and flexible to allow it to be applied to most biotech processes using an out of the box approach. Implementing EBR can be costly and require a high level of expertise. This novel OEM approach to EBR enables cost effective implementation for EBR for small to mid-sized biotech companies.
We’ll continue to share examples from the many knowledge-sharing presentations you’ll find at the conference. We hope you can get the approvals in place and make your plans to join us in Denver. It should be another great conference!
Until then, make sure to connect and interact with your peers in the groups of interest in the Emerson Exchange 365 community.